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Abstract Many emergency physicians struggle with the
clinical question of whether to perform therapeutic
hypothermia (TH) or coronary angiography (CAG) first after
return of spontaneous circulation (ROSC) in patients with
out-of-hospital cardiac arrest (OHCA). We analyzed the
results of the SOS-KANTO 2012 study, which is a
prospective, multicenter (67 emergency hospitals), obser-
vational study about OHCA conducted between January
2012 and March 2013 (n = 16,452). We compared two
groups: the group in which TH was first performed (TH
group), and the group in which CAG was performed first
(CAG group) within 24 h after arrival. Two hundred and
twenty-one patientswere treatedTHandCAG (THgroup, 76
patients; CAG group, 145 patients). In addition, we selected
patients who underwent coronary treatment. 164 patients
underwent coronary treatment after CAG (TH group, 52
patients; CAG group, 112 patients). In patients in whom TH
and CAG and coronary artery treatment were done, 42
patients (55.3 %) in the THgroup and 86 patients (59.3 %) in
the CAG group survived at 90 days. The cerebral perfor-
mance category (CPC) 1 and 2 were 26.3 % (20 patients) in
TH group, and 31.0 % (45 patients) in CAG group. In
patients in whom TH and CAG with coronary artery treat-
ment were performed, 29 patients (55.8 %) in the TH group
and 64 patients (57.1 %) in the CAG group survived at
90 days. The rates of CPC 1 and 2 were 26.9 % (14 patients)
in TH group, and 23.2 % (26 patients) in CAG group. There
was no significant difference in 90-day survival between the
two groups although it tended to be better in the CAG group
than in the TH group. Whether TH or CAG was performed
first did not affect the 90-day survival and 30-day neuro-
logical situation among patients with ROSC after OHCA.
Keywords Therapeutic hypothermia  Coronary
angiography  Out-of-hospital cardiac arrest
Introduction
Out-of-hospital cardiac arrest (OHCA) is one of the
greatest problems of community and public health. For
patients with OHCA to have a good prognosis, it is
essential not only to resuscitate precisely, but also to per-
form post-cardiac arrest care appropriately after return of
spontaneous circulation (ROSC).
In post-cardiac arrest care, therapeutic hypothermia (TH)
is a helpful approach for protection of the brain and other
organs in patients who remain comatose after ROSC [1, 2].
TH may be considered for comatose adult patients with
ROSC after OHCA according to the 2010 American Heart
Association (AHA) Guidelines for Cardiopulmonary Resus-
citation (CPR) and Emergency Cardiovascular Care (ECC)
[3]. Those guidelines recommend that the body temperature
should be cooled to 32–34 C for 12–24 h in TH.
On the other hand, the usefulness of emergent coronary
angiography (CAG) in survivors of OHCA has already
been reported [4, 5], and the 2010 AHA Guidelines for
CPR and ECC insist that emergent CAG may be reasonable
because of the high incidence of acute coronary ischemia in
OHCA patients [3]. In particular, percutaneous coronary
intervention (PCI), alone or as part of a bundle of care, is
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associated with improved myocardial function [4] and
neurological outcomes [5, 6]. However, the priority of TH
or CAG has not been established yet. So there are doctors
who are worried about the risk of pulmonary edema in
using low temperature hypothermia [7], and do not believe
there is convincing evidence to support the use of
hypothermia prior to CAG. Such doctors think TH (in-
cluding cooling blanket and ice packs) should start after
CAG/PCI. This study was projected for such doctors to
provide more evidence of early or simultaneous TH and
CAG.
A Survey of Survivors of OHCA in the Kanto district of
Japan 2012 study (SOS-KANTO 2012 study) was per-
formed by the Japanese Association for Acute Medicine in
Kanto district between January 2012 and March 2013, and
included 67 emergency hospitals and emergency medical
services units (26 academic medical centers). The SOS-
KANTO 2012 study was a prospective, multicenter,
observational study about OHCA.
We evaluate the priority of TH or CAG after ROSC in
patients with OHCA using the data of the SOS-KANTO
2012 study.
Methods
The SOS-KANTO 2012 study was a prospective, multi-
center (67 emergency hospitals), observational study con-
ducted between January 2012 and March 2013 on patients
with OHCA. The protocol of the SOS-KANTO 2012 study
was approved without the need for informed consent by the
research ethics board of Yokohama City University Med-
ical Center (Yokohama, Kanagawa, Japan; D1402005).
The total number of OHCA patients who were transferred
to the 67 emergency hospitals (26 academic medical cen-
ters), and the emergency hospitals that participated in the
SOS-KANTO 2012 study are listed in Acknowledgments.
The results of SOS-KANTO 2012 study are published in
several journals [8–11].
The study flow diagram is shown in Fig. 1. First, we
selected OHCA patients who underwent both TH and CAG
after ROSC within 24 h after arrival at the hospital from all
OHCA patients. Patients B 18 years were excluded.
Patients with missing data were also excluded. Then, these
patients were divided into the following two groups: (1)
TH was performed first prior to CAG (TH group), and (2)
CAG was performed first prior to TH (CAG group). Next,
we analyzed the patients who were treated with coronary
artery stenting. In this study, we defined CAG as only
coronary artery imaging using catheter.
The indications for CAG and coronary artery treatment
in patients with OHCA were decided by emergency
physicians and cardiologists at each hospital. TH was
defined as maintenance of core body temperature at
32–34 C for 12–24 h after ROSC, and the methodology of
TH was entrusted to each hospital.
The primary outcomes were 90-day survival and neu-
rological status, and the secondary outcomes were 30-day
neurological status and complications associated with TH.
Neurological status was described by cerebral performance
category (CPC) [12, 13]. Good neurological outcome was
defined as CPC1 and CPC2.
Statistical analysis
Differences between the groups were analyzed with Stu-
dent’s t test for normally distributed variables or Mann–
Whitney U test for non-normally distributed variables, and
the Fisher’s exact test for categorical variables. Survival
curves were drawn by the Kaplan–Meier method, and were
compared with the log-rank test.
IBM SPSS Statistics 22 and EZR (Saitama Medical
Center, Jichi Medical University, Saitama, Japan) were
used for statistical analyses. EZR is a graphical user
interface for R (The R Foundation for Statistical Comput-
ing, Vienna, Austria). More precisely, it is a modified
version of R commander designed to add statistical func-
tions frequently used in biostatistics [14]. Statistical sig-
nificance was assumed to be present at a p value of\0.05.
Results
During the study period, 16,452 patients were collected in
the SOS-KANTO 2012 study.
As shown in Fig. 1, both TH and CAG were performed
within 24 h after arrival at the hospital in 221 patients. TH
was performed first in 76 patients (TH group), and CAG
was performed first in 145 patients (CAG group). Among
them, there were 164 patients in whom the coronary
arteries were treated (52 patients in TH group, and 112
patients in CAG group).
Table 1 shows the characteristics of patients in the TH
(n = 76) and CAG (n = 145) groups who are with or
without coronary treatment. There were 61 males in TH
group, and 123 males in CAG group, respectively (p = 1).
The mean age ± standard deviation (SD) (years old) of TH
group is 60.4 ± 13.6, that of CAG group is 63.1 ± 11.2,
respectively (p = 0.11). The median time from arrival to
CAG start [±, interquartile range (IQR) (min)] in TH group
is 88.5 ± 70.5, in CAG group is 70.0 ± 46.0, respectively
(p = 0.014). The median time from arrival to reach the
target body temperature [± IQR (min)] in TH group is
155 ± 249.5, in CAG group is 300 ± 225, respectively
(p\ 0.001). The median time from TH start to reach the
target body temperature [± IQR (min)] in TH group is
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Fig. 1 The study flow diagram
Table 1 Patients’ characteristics of the TH group and CAG group (TH and CAG with or without coronary artery treatment was performed in all
patients)
TH group (N = 76) CAG group (N = 145) p
Sex (M/F) (N) 61/12 123/22 1
Mean age (years old) ± SD 60.4 ± 13.6 63.1 ± 11.2 0.11
Median time from amvai to CAG start [± IQR (min)] 88.5 ± 70.5 70 ± 46 0.014
Median time from amvai to reach the target body temperature [± IQR (min)] 155 ± 249.5 300 ± 225 \0.001
Median time from TH start to reach the target body temperature [± IQR (min)] 105 ± 210 161.5 ± 154.6 0.191
Witnessed [N (%)] 61 (80.3) 115 (79.3) 1
by-stander CPR [N (%)] 45 (59.2) 73 (50.3) 0.552
ECG waveform at first [N (%)]
VF/VT 52 (68.4)/0 (0) 84 (57.9)/0 (0) 0.496
PEA 7 (9 2) 29 (20 0) 0.085
Asystole 6 (7 9) 8 (5 5) 0.568
Other 10 (13 2) 24 (16 6) 0.698
ECG waveform arrival [N (%)]
VF/VT 17 (22 4)/0 (0) 26 (17.9)/0 (0) 0.601
PEA 14 (18 4) 32 (22 1) 0.732
Asystole 10 (132) 22 (15 2) 0.843
Other 35 (46 1) 65 (44 8) 1
With ECMO [N (%)] 34 (44 7) 45 (31 0) 0.177
With IABP [N (%)] 41 (53 9) 73 (50 3) 0.809
With BP [N (%)] 4 (5 3) 20 (13 8) 0.108
TH therapeutic hypothermia, CAG coronary angiography, SD standard deviation, IQRt interquartile range, CPR cardiopulmonary resuscitation,
ECG electrocardiogram, VF/VT ventricular fibrillation pulseless ventricular tachycardia, PEA pulseless electrical activity, ECMO extracorporeal
membrane oxygenation, IAPB intra-aortic balloon pumping, BP blood purification
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105 ± 210, in CAG group is 161.5 ± 154.6, respectively
(p = 0.191). There were 61(80.3 %) patients with wit-
nessed arrest in the TH group, and 115 (79.3 %) patients
with witnessed arrest in the CAG group, respectively
(p = 1). There were 45 (59.2 %) patients with by-stander
CPR in the TH group, and 73 (50.3 %) patients with by-
stander CPR in the CAG group, respectively (p = 0.552).
There were 52 (68.4 %) patients who were in ventricular
fibrillation/pulseless ventricular tachycardia (VF/VT) in the
TH group, and there were 84 (57.9 %) patients that were in
VF/VT in the CAG group in the electrocardiogram (ECG)
wave form at first, respectively (p = 0.496). There were 17
(22.4 %) patients in VF/VT in the ECG wave form at
arrival in TH group, and there were 26 (17.9 %) patients in
CAG group, respectively (p = 0.601). There were 34
(44.7 %) patients who were treated with extra corporeal
membrane oxygenation (ECMO) in the TH group, and
there were 45 (31.0 %) patients who were treated ECMO in
CAG group, respectively (p = 0.177). There were 41
(53.9 %) patients who were treated with intra-aortic bal-
loon pumping (IABP) in the TH group, and there were 73
(50.3 %) patients who were treated with IABP in the CAG
group, respectively (p = 0.809). There were 4 (5.3 %)
patients who were treated with blood purification (BP)
including hemodialysis (HD) or continuous hemodiafiltra-
tion (CHDF) in the TH group, and there were 20 (13.8 %)
patients who were treated with BP in the CAG group,
respectively (p = 0.108).
Table 2 shows characteristics of the patients who
received coronary artery treatment (52 patients in TH
group, and 112 patients in CAG group). Fifty patients were
treated with catheter, and 2 patients were treated other
methods in the TH group, 109 patients were treated with
catheter and 3 patients with other methods in the CAG
group. There were 44 males in the TH group, and 96 males
in the CAG group, respectively (p = 1). The mean
age ± SD (years old) of the TH group was 62.2 ± 11.3,
that of the CAG group was 63.1 ± 11.5, respectively
(p = 0.652). The median time from arrival to CAG start
[± (IQR) (min)] in the TH group was 83.5 ± 65.3, in the
CAG group was 69.5 ± 44.8, respectively (p = 0.062).
The median time from arrival to reach the target body
temperature [± IQR (min)] in the TH group is
147 ± 243.8, in the CAG group is 300 ± 232.3, respec-
tively (p\ 0.001). The median time from TH start to reach
the target body temperature [± IQR (min)] in the TH group
is 120 ± 192, is 180 ± 150 in the CAG group, respec-
tively (p = 0.259). There were 42 (80.8 %) patients with
witnessed in the TH group, and 87 (77.7 %) patients with
witnessed in the CAG group, respectively (p = 0.9). There
were 30 (57.7 %) patients with by-stander CPR in the TH
group, and 56 (50.0 %) patients with by-stander CPR in the
CAG group, respectively (p = 0.671). There were 35
(67.3 %) patients who were VF/VT in the TH group, and
62 (55.4 %) in VF/VT in the CAG group in the ECG wave
form at first, respectively (p = 0.498). There were 10
(19.2 %) patients in VF/VT in the ECG wave form at
arrival in the TH group, and there were 20 (17.9 %)
patients in the CAG group, respectively (p = 0.835). There
were 22 (42.3 %) patients who were treated ECMO in the
TH group, and there were 38 (33.9 %) patients who were
treated with ECMO in the CAG group, respectively
(p = 0.523). There were 31 (59.6 %) patients who were
treated with IABP in the TH group, and there were 64
(57.1 %) patients who were treated with IABP in the CAG
group, respectively (p = 0.891). There were 3 (5.8 %)
patients who were treated with BP in the TH group, and
there were 17 (15.2 %) patients who were treated with BP
in the CAG group, respectively (p = 0.194).
We could analyze the time from arrival to coronary
reperfusion [coronary reperfusion was defined as throm-
bolysis in myocardial infarction (TIMI) grade 2 or 3] in
only 124 patients (TH group: N = 37, CAG group:
N = 87). The median time from arrival to coronary
reperfusion [± IQR (min)] is 162 ± 73 in the TH group,
and 120 ± 69 in the CAG group, respectively (p\ 0.001).
Primary outcomes
Figure 2a shows the Kaplan–Meier survival curves of
patients in whom TH and CAG with or without coronary
artery treatment were done. At 90 days, 42 patients
(55.3 %) in the the TH group and 86 patients (59.3 %) in
the the CAG group survived. Estimated mean survival day
is 52.6 (standard error: 5.8, 95 % confidence interval
41.2–63.9) days in the TH group and estimated mean
survival day was 55.3 (standard error: 3.8, 95 % confidence
interval 47.8–62.8) days in the CAG group, respectively.
Figure 2b shows the Kaplan–Meier survival curves of
patients in whom TH and CAG with coronary artery
treatment were performed. At 90 days, 29 patients
(55.8 %) in the TH group and 64 patients (57.1 %) in the
CAG group survive. Estimated mean survival day is 51.6
(standard error: 4.8, 95 % confidence interval 42.2–61.1)
days in TH group, and estimated mean survival day is 56.9
(standard error: 3.3, 95 % confidence interval 50.3–63.4)
days in the CAG group, respectively. As shown in the two
figures, there is no significant difference in 90-day survival
between the two groups although it tended to be better in
the CAG group than in the TH group.
Table 3 shows the 90-day neurological prognosis of
patients. As shown in Table 3, there is no significant dif-
ference in the rate of patients with good neurological
prognosis at 90 days between the two groups.
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Table 2 Patients’ characteristics of the TH group and CAG group (TH and CAG with coronary artery treatment were performed in all patients)
TH group (N = 52) CAG group (N = 112) p
Sex(W/F) (N) 44/8 96/16 1
Mean age (years old) ± SD 62.2 ± 1.13 63.1 ± 11.5 0.652
Median time from arrival to CAG start [± IQR (min)] 83.5 ± 65.3 69.5 ± 44.75 0.062
Median time from arrival to reach the target body temperature [± IQR (min)] 147 ± 243 8 300 ± 232.3 \0.001
Median time from TH start to teach the target body temperature [± IQR (min)] 120 ± 192 180 ± 150 0.259
Median time from arrival to coronary reperfusion [± IQR (min)] 162 ± 73* 120 ± 69** \0.001
Witnessed [N (%)] 42 (80.8) 87 (77.7) 0.9
By-stander CPR [N (%)] 30 (57.7) 56 (50) 0.671
ECG waveform at first [N (%)]
VF/VT 35 (67.3)/0 (0) 62 (55 4)/0 (0) 0.498
PEA 6 (115) 24 (214) 0.278
Asystole 2 (3.8) 6 (5.4) 1
Other 9 (17.3) 20 (17.9) 1
ECG waveform at arrival [N (%)]
VF/VT 10 (19.2)/0 (0) 20(17.9)/0 0.35
PEA 12 (23.1) 26 (23.2) 1
Asystole 7 (13.5) 16 (14.3) 1
Other 23 (44.2) 50 (44.6) 1
With ECMO [N (%)] 22 (42.3) 38 (33.9) 0.523
With IABP [N (%)] 31 (59.6) 64 (57.1) 0.891
With BP [N (%)] 3 (58) 17 (15.2) 0.194
TH therapeutic hypothermia, CAG coronary angiography, SD standard deviation, IQRt interquartile range, CPR cardiopulmonary resuscitation,
ECG electrocardiogram, VF/VT ventricular fibrillation/pulseless ventricular tachycardia, PEA pulseless electrical activity, ECMO extracorporeal
membrane oxygenation, IAPB intra-aortic balloon pumping, BP blood purification
*N = 37; **N = 87
Fig. 2 a Kaplan–Meier curves of the TH group and CAG group with
and without coronary artery treatment. There was no significant
difference between the two groups (log-rank test). b Kaplan–Meier
curves of the TH group and CAG group with coronary artery
treatment. There is no significant difference between the two groups
(log-rank test). TH Therapeutic hypothermia, CAG coronary
angiography
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Secondary outcomes
The secondary outcomes are shown in Table 4.
Regardless of the coronary treatment, patients whose
CPC are 1 or 2 are 23 (30.3 %) patients in the TH group,
and 50 (34.5 %) patients in the CAG group in 30 days,
respectively. Complications of hypothermia are seen in 24
(31.6 %) patients in the TH group, and 41 (28.3 %)
patients in the CAG group between 90 days, and 3 (3.9 %)
died from complications of hypothermia in the TH group,
and 5 (3.4 %) were died in the CAG group.
Patients with coronary treatment, patients whose CPC
were 1 or 2 are 17 (32.7 %) patients in the TH group, and
32 (28.6 %) patients in the CAG group in 30 days,
respectively. The complications of hypothermia are seen in
22 (42.3 %) patients in the TH group, and in 29 (25.9 %)
patients in the CAG group between 90 days. Two (3.8 %)
died from complications of hypothermia in the TH group,
and 3 (2.7 %) died in the CAG group.
There are no significant differences in the rate of good
neurological prognosis at 30 days, complications of
hypothermia, and death caused by complications of
hypothermia between the two groups.
Discussion
All healthcare workers involved in emergency medicine
have been trying to improve the prognosis of patients with
cardiac arrest. Recently, it had been reported that
hypothermia was an effective treatment to improve the
neurological situation and survival of comatose patients
after ROSC [1, 2], and the usefulness of hypothermia
recommended in the 2005 AHA Guidelines for CPR and
ECC. Thereafter, the effectiveness of TH for comatose
patients after ROSC has often been reported [15–17], and
the 2010 AHA Guidelines for CPR and ECC recommended
performing TH in comatose adult patients with ROSC after
OHCA (class I–IIb) [3].
On the other hand, Spaulding et al. [4] report that
accurate diagnosis by immediate CAG will yield suit-
able candidates for coronary angioplasty, and it seems to
improve survival in patients with OHCA. Thereafter, the
number of papers that reported the effectiveness of early
CAG with potential coronary artery treatment in patients
with ROSC after OHCA increased [4, 18–20], and the
usefulness of early CAG and coronary artery treatment was
described in the 2010 AHA Guidelines for CPR and ECC
[3]. Recent reports have recommended both TH and CAG
with coronary artery treatment [17, 21].
It seems to be ideal to start both TH and CAG in patients
with OHCA immediately after arrival. However, there are
doctors who concerned that there is an increase in pul-
monary edema with the use of low-temperature infusion
[7]. It is difficult for such doctors to start both TH and CAG
at the same time. Additionally, all hospitals cannot always
conduct immediate CAG for patients after ROSC. How-
ever, TH could be started if physicians experienced with
TH after ROSC happen to be in the hospital. On the other
hand, for CAG, cardiologists who are familiar with CAG
are necessary. Many emergency physicians, cardiologists
and intensivists have struggled with the clinical question of
whether to start TH or CAG first after ROSC; however,
there is no description about that in the 2010 AHA
Guidelines for CPR and ECC. Therefore, we evaluated this
point using data of the SOS-KANTO 2012 study.
We find that there are no statistically significant differ-
ences in survival and the 90-day neurological prognosis as
Table 3 Primary outcome: 90-day neurological situation
With and without coronary artery treatment With coronary artery treatment
TH group (N = 76) CAG group (N = 145) p TH group (N = 52) CAG group (N = 112) p
CPC1?2 [N (%)] 20 (26.3) 45 (31.0) 0.655 14 (26.9) 26 (23.2) 0.709
Table 4 Secondary outcome










30-day neurological status CPC1?2
[N (%)]
23 (30.3) 50 (34.5 %) 0.672 17 (32.7) 32 (23.6) 0.729
With complications of hypothermia
[N (%)]
24 (31.6) 41 (28.3) 0.768 22 (42.3) 29 (25.9) 0.177
Death caused by complications 3 (3.9) 5 (3.4) 1 2 (3.8 %) 3 (2.7 %) 0.655
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primary outcomes, and in the 30-day neurological prog-
nosis as the secondary outcome between the two groups
regardless of coronary artery treatment. However, our
finding that the survival rate tended to be better in the CAG
group might have been influenced by type-II error because
there were a small number of patients that were finally
targeted for analysis. In addition, this result might indicate
the importance of stabilizing hemodynamics first, so the
survival curve of the CAG group may be better than that of
the TH group without a statistical significant difference. On
the other hand, Laver et al. [22] report that two-thirds of
patients who die after OHCA die due to neurological injury
and mortality is not associated with the ECG wave form of
the cardiac arrest. In the present study, there is no signifi-
cant difference in the 90-day neurological prognosis, and
this result may have influenced the survival rate.
Regarding the secondary outcome, there are no signifi-
cant differences in the rate of complications associated
with hypothermia. This indicates that CAG can be per-
formed safely with TH.
Temperature management for patients after ROSC is
important. In this studywecould not discernwhat temperature
of hypothermia is best. The report of TTM trial investigators
mentions that there are no significant differences between 33
and 36 C in patients who are treated with temperature man-
agement after ROSC [23]. In their report, the Kaplan–Meier
curves of both groups are almost same. On the other hand,
Kaplan–Meier curve of the CAG group is better than the TH
group (of course there is no significant difference as pointed
out above), so there is a possibility that CAG first produces a
better outcome than TH first in OHCA patients.
Limitations
The SOS-KANTO study 2012 was a large, prospective
cohort study of OHCA; however, the number of patients
who underwent both TH and CAG was small, and this was
only an observational study. This study did not include all
hospitals with an emergency center in the KANTO area in
Japan, and there is a possibility that our results are influ-
enced by type-II error. There may have been differences in
the indication to perform CAG and coronary artery treat-
ment among the hospitals. In addition, the methods and
apparatus for TH were varied and not unified. Therefore, a
randomized double-blind trial would be preferable.
Conclusion
Whether TH or CAG was performed earlier did not
affect the survival and neurological prognosis after
90 days and 30-day neurological prognosis among
patients with ROSC after OHCA. Regarding the priority
of TH or CAG, either TH or CAG can be immediately
started in the hospital for comatose patients with ROSC
after OHCA.
Author Contributions SOS-KANTO 2012 Steering Council—
Yokohama City University Medical Center, Kanagawa (President,
Naoto Morimura, MD); Nihon University School of Medicine,
Tokyo (Director, Atsushi Sakurai, MD); National Cerebral and
Cardiovascular Center Hospital, Osaka (Director, Yoshio Tahara,
MD); Tokyo Women’s Medical University Hospital, Tokyo (Arino
Yaguchi, MD); Nihon University Surugadai Hospital, Tokyo (Ken
Nagao, MD); Nippon Medical School Hospital, Tokyo (Tagami
Takashi, MD); Japanese Red Cross Maebashi Hospital, Gunma (Dai
Miyazaki, MD); National Disaster Medical Center, Tokyo (Tomoko
Ogasawara, MD); Keio University Hospital, Tokyo (Kei Hayashida,
MD, Masaru Suzuki, MD); Tokai University School of Medicine,
Kanagawa (Mari Amino, MD); Kimitsu Chuo Hospital, Chiba
(Nobuya Kitamura, MD); Juntendo University Nerima Hospital,
Tokyo (Tomohisa Nomura, MD); Tokyo Metropolitan Children’s
Medical Centre, Tokyo (Naoki Shimizu, MD); Tokyo Metropolitan
Bokutoh Hospital, Tokyo (Akiko Akashi, MD), National Center of
Neurology and Psychiatry, Tokyo, Japan (Naohiro Yonemoto,
DPH). SOS-KANTO 2012 Study Group—Tokai University School
of Medicine (Sadaki Inokuchi, MD); St. Marianna University
School of Medicine, Yokohama Seibu Hospital (Yoshihiro Masui,
MD); Koto Hospital (Kunihisa Miura, MD); Saitama Medical
Center Advanced Tertiary Medical Center (Haruhiko Tsutsumi,
MD); Kawasaki Municipal Hospital Emergency and Critical Care
Center (Kiyotsugu Takuma, MD); Yokohama Municipal Citizen’s
Hospital (Ishihara Atsushi, MD); Japanese Red Cross Maebashi
Hospital (Minoru Nakano, MD); Juntendo University Urayasu
Hospital (Hiroshi Tanaka, MD); Dokkyo Medical University
Koshigaya Hospital (Keiichi Ikegami, MD); Hachioji Medical
Center of Tokyo Medical University (Takao Arai, MD); Tokyo
Women’s Medical University Hospital (Arino Yaguchi, MD);
Kimitsu Chuo Hospital (Nobuya Kitamura, MD); Chiba University
Graduate School of Medicine (Shigeto Oda, MD); Saiseikai Utsu-
nomiya Hospital (Kenji Kobayashi, MD); Mito Saiseikai General
Hospital (Takayuki Suda, MD); Dokkyo Medical University
(Kazuyuki Ono, MD); Yokohama City University Medical Center
(Naoto Morimura, MD); National Hospital Organization Yokohama
Medical Center (Ryosuke Furuya, MD); National Disaster Medical
Center (Yuichi Koido, MD); Yamanashi Prefectural Central
Hospital (Fumiaki Iwase, MD); Surugadai Nihon University
Hospital (Ken Nagao, MD); Yokohama Rosai Hospital (Shigeru
Kanesaka, MD); Showa General Hospital (Yasusei Okada, MD);
Nippon Medical School Tamanagayama Hospital (Kyoko Unemoto,
MD); Tokyo Women’s Medical University Yachiyo Medical Center
(Tomohito Sadahiro, MD); Awa Regional Medical Center
(Masayuki Iyanaga, MD); Todachuo General Hospital (Asaki
Muraoka, MD); Japanese Red Cross Medical Center (Munehiro
Hayashi, MD); St. Luke’s International Hospital (Shinichi Ishi-
matsu, MD); Showa University School of Medicine (Yasufumi
Miyake, MD); Totsuka Kyoritsu Hospital (Hideo Yokokawa, MD);
St. Marianna University School of Medicine (Yasuaki Koyama,
MD); National Hospital Organization Mito Medical Center (Asuka
Tsuchiya, MD); Tokyo Metropolitan Tama Medical Center (Tet-
suya Kashiyama, MD); Showa University Fujigaoka Hospital
(Munetaka Hayashi, MD); Gunma University Graduate School of
Medicine (Kiyohiro Oshima, MD); Saitama Red Cross Hospital
(Kazuya Kiyota, MD); Tokyo Metropolitan Bokutoh Hospital
(Yuichi Hamabe, MD); Nippon Medical School Hospital (Hiroyuki
Yokota, MD); Keio University Hospital (Shingo Hori, MD); Chiba
Emergency Medical Center (Shin Inaba, MD); Teikyo University
Intern Emerg Med (2016) 11:577–585 583
123
School of Medicine (Tetsuya Sakamoto, MD); Japanese Red Cross
Musashino Hospital (Naoshige Harada, MD); National Center for
Global Health and Medicine Hospital (Akio Kimura, MD); Tokyo
Metropolitan Police Hospital (Masayuki Kanai, MD); Medical
Hospital of Tokyo Medical and Dental University (Yasuhiro
Otomo, MD); Juntendo University Nerima Hospital (Manabu
Sugita, MD); Nihon University School of Medicine (Kosaku
Kinoshita, MD); Toho University Ohashi Medical Center (Taka-
toshi Sakurai, MD); Saiseikai Yokohamashi Tobu Hospital (Mit-
suhide Kitano, MD); Nippon Medical School Musashikosugi
Hospital (Kiyoshi Matsuda, MD); Tokyo Rosai Hospital (Kotaro
Tanaka, MD); Toho University Omori Medical Center (Katsunori
Yoshihara, MD); Hiratsuka City Hospital (Kikuo Yoh, MD);
Yokosuka Kyosai Hospital (Junichi Suzuki, MD); Saiseikai Yoko-
hamashi Nambu Hospital (Hiroshi Toyoda, MD); Nippon Medical
School Chiba Hokusoh Hospital (Kunihiro Mashiko, MD); Tokyo
Metropolitan Children’s Medical Centre (Naoki Shimizu, MD);
National Medical Center for Children and Mothers (Takashi
Muguruma, MD); Chiba Aoba Municipal Hospital (Tadanaga Shi-
mada, MD); Kuki General Hospital (Yoshiro Kobe, MD); Matsudo
City Hospital (Tomohisa Shoko, MD); Japanese Red Cross Narita
Hospital (Kazuya Nakanishi, MD); Tokyo Bay Urayasu/Ichikawa
Medical Center (Takashi Shiga, MD); NTT Medical Center Tokyo
(Takefumi Yamamoto, MD); Tokyo Saiseikai Central Hospital
(Kazuhiko Sekine, MD); Fuji Heavy Industries Health Insurance
Society OTA Memorial Hopital (Shinichi Izuka, MD). (http://www.
jaam- kanto.jp/sos_kanto/sos_kanto2012_contributors.html).
Funding Sources This study was supported by Japanese Associa-
tion for Acute Medicine of Kanto.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict
of interest.
Statement of human and animal rights All procedures performed
in studies involving human participants were in accordance with the
ethical standards of the intstitutional or national resarch committee,
and with the 1964 Helsinki declaration and its later amendments or
comparable ethical standards.
Informed consent The protocol of this study was approved without
the need for informed consent by the research ethics board of
Yokohama City University Medical Center (Yokohama, Kanagawa,
Japan).
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
Appendix
The SOS-KANTO 2012 study group members: Shuichi
Hagiwara, Kiyohiro Oshima, Kei Hayashida, Atushi
Sakurai, Yoshio Tahara, Ken Nagao, Naohiro Yonemoto,
Arino Yaguchi, and Naoto Morimura.
References
1. Hypothermia after cardiac arrest study group (2002) Mild ther-
apeutic hypothermia to improve the neurologic outcome after
cardiac arrest. N Engl J Med 346:549–556. doi:10.1056/
NEJMoa012689
2. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W,
Gutteridge G, Smith K (2002) Treatment of comatose survivors
of out-of-hospital cardiac arrest with induced hypothermia.
N Engl J Med 346:557–563. doi:10.1056/NEJMoa003289
3. Peberdy MA, Callaway CW, Neumar RW, Geocadin RG, Zim-
merman JL, Donnino M, Gabrielli A, Silvers SM, Zaritsky AL,
Merchant R, Vanden Hoek TL, Kronick SL (2010) Part 9: post-
cardiac arrest care:2010 American heart association guidelines
for cardiopulmonary resuscitation and emergency cardiovascular
care. Circulation 122:S768–S786. doi:10.1161/CIRCULATIO
NAHA.110.971002
4. Spaulding CM, Joly LM, Rosenberg A, Monchi M, Weber SN,
Dhainaut JF, Carli P (1997) Immediate coronary angiography in
survivors of out-of-hospital cardiac arrest. N Engl J Med
336:1629–1633. doi:10.1056/NEJM199706053362302
5. Reynolds JC, Callaway CW, El Khoudary SR, Moore CG,
Alvarez RJ, Rittenberger JC (2009) Coronary angiography pre-
dicts improved outcome following cardiac arrest: propensity-ad-
justed analysis. J Intensive Care Med 24:179–186. doi:10.1177/
0885066609332725
6. Sunde K, Pytte M, Jacobsen D, Mangschau A, Jensen LP,
Smedsrud C, Draegni T, Steen PA (2007) Implementation of a
standardized treatment protocol for post resuscitation care after
out-of-hospital cardiac arrest. Resuscitation 73:29–39. doi:10.
1016/j.resuscitation.2006.08.016
7. Kim F, Nichol G, Maynard C, Hallstrom A, Kudenchuk PJ, Rea
T, Copass MK, Carlbom D, Deem S, Longstreth WT Jr, Olsufka
M, Cobb LA (2014) Effect of prehospital induction of mild
hypothermia on survival and neurological status among adults
with cardiac arrest: a randomized clinical trial. JAMA
311(1):45–52. doi:10.1001/jama.2013.282173
8. SOS-KANTO study group (2015) Changes in pre- and in-hospital
management and outcomes for out-of-hospital cardiac arrest
between 2002 and 2012 in Kanto, Japan: the SOS-KANTO 2012
Study. Acute Med Surg 2:225–233. doi:10.1002/ams2.102
9. SOS-KANTO study group (2015) Changes in treatments and
outcomes among elderly patients with out-of-hospital cardiac
arrest between 2002 and 2012: a post hoc analysis of the SOS-
KANTO 2002 and 2012. Resuscitation 97:76–82. doi:10.1016/j.
resuscitation.2015.09.379
10. Kitamura N, Nakada TA, Shinozaki K, Tahara Y, Sakurai A,
Yonemoto N, Nagao K, Yaguchi A, Morimura N (2015) Subse-
quent shock deliveries are associated with increased favorable
neurological outcomes in cardiac arrest patients who had initially
non-shockable rhythms. Crit Care 19:322. doi:10.1186/s13054-
015-1028-0
11. Amino M, Inokuchi S, Nagao K, Nakagawa Y, Yoshioka K, Ikari
Y, Funakoshi H, Hayakawa K, Matsuzaki M, Sakurai A, Tahara
Y, Yonemoto N, Yaguchi A, Morimura N (2015) Nifekalant
hydrochloride and amiodarone hydrochloride result in similar
improvements for 24-hour survival in cardiopulmonary arrest
patients: the SOS-KANTO 2012 study. J Cardiovasc Pharmacol
66:600–609. doi:10.1097/FJC.000000000000310
12. Cummins RO, Chamberlain DA, Abramson NS, Allen M, Baskett
PJ, Becker L, Bossaert L, Delooz HH, Dick WF, Eisenberg MS,
Evans TR, Holmberg S, Kerber R, Mullie A, Ornat JP, Sandoe E,
Skulberg A, Tunstall-Padoe H, Swanson R, Thies WH (1991)
Recommended guidelines for uniform reporting of data from out-
584 Intern Emerg Med (2016) 11:577–585
123
of-hospital cardiac arrest: the Utstein Style. A statement for
health professionals from a task force of the American Heart
Association, the European Resuscitation Council, the Heart and
Stroke Foundation of Canada, and the Australian Resuscitation
Council. Circulation 84:960–975. doi:10.1161/01.CIR.84.2.960
13. Jacobs I, Nadkarni V, Bahr J, Berg RA, Billi JE, Bossaert L,
Cassan P, Coovadia A, D’Este K, Finn J, Halperin H, Handley A,
Herlitz J, Hickey R, Idris A, Kloeck W, Larkin GL, Mancini ME,
Mason P, Mears G, Monsieurs K, Montgomery W, Morley P,
Nichol G, Nolan J, Okada K, Perlman J, Shuster M, Steen PA,
Sterz F, Tibballs J, Timerman S, Truitt T, Zideman D (2004)
Cardiac arrest and cardiopulmonary resuscitation outcome
reports: update and simplification of the Utstein templates for
resuscitation registries: a statement for healthcare professionals
from a task force of the International Liaison Committee on
Resuscitation (American Heart Association, European Resusci-
tation Council, Australian Resuscitation Council, New Zealand
Resuscitation Council, Heart and Stroke Foundation of Canada,
Inter American Heart Foundation, Resuscitation Councils of
Southern Africa). Circulation 110:3385–3397. doi:10.1161/01.
CIR.0000147236.85306.15
14. Kanda Y (2013) Investigation of the freely-available easy-to-use
software ‘‘EZR’’ (Easy R) for medical statistics. Bone Marrow
Transplant 48:452–458. doi:10.1038/bmt.2012.244
15. Kern KB (2012) Optimal treatment of patients surviving out-of-
hospital cardiac arrest. JACC Cardiovasc Interv 5:597–605.
doi:10.1016/j.jcin.2012.01.017
16. Zimmermann S, Flachskampf FA, Schneider R, Dechant K, Alff
A, Klinghammer L, Rittger H, Achenbach S (2013) Mild thera-
peutic hypothermia after out-of-hospital cardiac arrest compli-
cating ST-elevation myocardial infarction: long-term result in
clinical practice. Clin Cardiol 36:414–421. doi:10.1002/clc.22131
17. Stub D, Hengel C, Chan W, Jackson D, Sanders K, Dart AM,
Hilton A, Pellegrino V, Shaw JA, Duffy SJ, Bernard S, Kaye DM
(2011) Usefulness of cooling and coronary catheterization to
improve survival in out-of hospital cardiac arrest. Am J Cardiol
107:522–527. doi:10.1016/j.amjcard
18. Cronier P, Vignon P, Bouferrache K, Aegerter P, Charron C,
Templier F, Castro S, El Mahmoud R, Lory C, Pichon N,
Dubourg O, Vieillard-Baron A (2011) Impact of routine percu-
taneous coronary intervention after out-of-hospital cardiac arrest
due to ventricular fibrillation. Crit Care 2011 15:R122. doi:10.
1186/cc10227
19. Callaway CW, Schmicker RH, Brown SP, Albrich JM, Andrusiek
DL, Aufderheide TP, Christenson J, Daya MR, Falconer D, Husa
RD, Idris AH, Ornato JP, Rac VE, Rea TD, Rittenberger JC,
Sears G, Stiell IG (2014) Early coronary angiography and
induced hypothermia are associated with survival and functional
recovery after out-of-hospital cardiac arrest. Resuscitation
85:657–663. doi:10.1016/j.resuscitation.2013.12.028
20. Vaillant C, Leurent G, Garlantezec R, Thebault C, Martins R, Bot
E, Coudert I, Boulmier D, Le Breton H, Bedossa M (2013)
Coronary angioplasty is associated with a better nerurological
outcome in the era of modern management if out-of-hospital
cardiac arrest. Int J Cardiol 169:e91–e92. doi:10.1016/j.ijcard.
2013.10.037
21. Dumas F, White L, Stubbs BA, Cariou A, Rea TD (2012) Long-
term prognosis following resuscitation from out of hospital car-
diac arrest. J Am Coll Cardiol 60:21–27. doi:10.1016/j.jacc
22. Laver S, Farrow C, Turner D, Nolan J (2004) Mode of death after
admission to an intensive care unit following cardiac arrest.
Intensive Care Med 30:2126–2128. doi:10.1007/s00134-004-
2425-z
23. Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y,
Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, Pellis
T, Stammet P, Wanschcher M, Wise MP, Aneman A, Al-Subaie
N, Boesgaard S, Bro-Jeppesen J, Brunetti I, Bugge JF, Hingston
CD, Juffermans NP, Koopmans M, Kober L, Langorgen J, Lilja
G, Moller JE, Rundgren M, Rylander C, Smid O, Werer C,
Winkel P, Friberg H (2013) Target temperature management at
33 C versus 36 C after cardiac arrest. N Engl J Med
369:2197–2206. doi:10.1056/NEJMoa1310519
Intern Emerg Med (2016) 11:577–585 585
123
